DAVID KAPLAN, M.D.; HERBERT S. DIAMOND, M.D.; ELLEN M. GINZLER, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Two clinical studies and an editorial in the November 1975 Annals (1-3) and another study cited (4, 5) conclude that azathioprine is of no demonstrable benefit in the management of patients with lupus nephritis—disagreeing with two other reports (6, 7). It is true that if a large number of clinics each study an ineffective drug in a small number of patients, it is likely that, by chance, a few clinics will show a "statistical" advantage of the drug. It is equally true, however, that among the same clinics studying an effective drug, each again in a small
KAPLAN D, DIAMOND HS, GINZLER EM. Treatment of Lupus Erythematosus. Ann Intern Med. ;84:337–338. doi: 10.7326/0003-4819-84-3-337
Download citation file:
Published: Ann Intern Med. 1976;84(3):337-338.
Lupus Erythematosus, Rheumatology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use